NASDAQ: TVGN
Tevogen Inc Earnings Dates, Reports, Calls

Tevogen earnings were -$22.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest TVGN earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$5.8M, up 3.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TVGN reported annual earnings of -$26.8M, with 161.1% growth.

TVGN earnings history

Current Revenue
$0.0
Current Earnings
-$22.1M
Current Profit Margin
0%

TVGN Return on Equity

Insufficient data to display

TVGN Return on Assets

Current Company
-478.1%
Current Industry
-10.2%
TVGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TVGN announces earnings.

TVGN Return on Capital Employed

Current Company
1,534.86%
Current Industry
-6.7%
TVGN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TVGN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TVGN-$21.61M-$22.14MN/A-$6.71
IMMPN/A-$59.52MN/A-$0.41
ANVS-$49.52M-$49.52MN/A-$1.79
GRCE-$21.91M-$20.22MN/A-$1.17
TIL-$23.47M-$30.28MN/A-$4.43

Tevogen Earnings Reports & History FAQ

What were Tevogen's earnings last quarter?

On TVGN's earnings call on Aug 18, 2026, Tevogen (NASDAQ: TVGN) reported Q2 2026 earnings per share (EPS) of -$1.52, up 11.11% year over year. Total TVGN earnings for the quarter were -$5.84 million. In the same quarter last year, Tevogen's earnings per share (EPS) was -$1.71.

If you're new to stock investing, here's how to buy Tevogen stock.

Is Tevogen profitable or losing money?

As of the last Tevogen earnings report, Tevogen is currently losing money. Tevogen's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$22.14 million, a 29.63% decrease year over year.

What was TVGN's earnings growth in the past year?

As of Tevogen's earnings date in Aug 18, 2026, Tevogen's earnings has grown year over year. TVGN earnings in the past year totalled -$22.14 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.